Pfizer Inc.
PFE
#136
Rank
$161.301 B
Marketcap
United States
Country
$28.30
Share price
6.31%
Change (1 day)
15.02%
Change (1 year)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under…
Key Metrics
Trailing P/E
36.39
Forward P/E
9.55
EPS (TTM)
$0.76
Forward EPS
$2.90
Price / Book
1.85
EV / EBITDA
8.3x
Beta
0.30
Dividend Yield
6.22%
Return on Equity
5.01%
Return on Assets
5.78%
Debt / Equity
74.25
Current Ratio
1.27
Gross Margin
74.72%
Operating Margin
27.88%
Net Profit Margin
6.80%
Free Cash Flow
$12.486B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 18
-2.05%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$62.579B
Latest Net Income$7.771B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Pfizer Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
PFE
No recent news available. Set FINNHUB_API_KEY to enable news.
